News about Clinical Trials

Basilea Secures Global Rights to Venatorx's Phase 3-Ready Oral Antibiotic Combination for Complicated UTIs

The oral beta-lactam/beta-lactamase inhibitor (BL/BLI) combination is phase 3-ready and being developed as a potential treatment for complicated urinary tract infections (cUTI), including pyelonephritis.

Clinical Trials | 16/08/2025 | By Darshana |  220

Novartis Advances Ianalumab Toward Approval for Sjogren's Disease After Phase III Success

Novartis has reported positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjogren's disease.

Clinical Trials | 11/08/2025 | By Dineshwori |  251

Sun Pharma's Phase 3 Clinical Trials of ILUMYA in Active Psoriatic Arthritis Achieve Primary Endpoint

Sun Pharmaceutical Industries has reported positive top-line results from two Phase 3 trials (INSPIRE-1 and INSPIRE-2), demonstrating that ILUMYA (tildrakizumab 100 mg) significantly improved symptoms of active psoriatic arthritis over 24 weeks compared to placebo.

Clinical Trials | 21/07/2025 | By Mrinmoy Dey |  322

CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal

For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.

Clinical Trials | 11/07/2025 | By Dineshwori |  386

Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment

Klotho Neurosciences has announced the initiation of manufacturing and process development for KLTO-202, its investigational gene therapy targeting ALS, with plans to begin clinical trials by Q3 next year.

Clinical Trials | 02/07/2025 | By Mrinmoy Dey |  296

Experts to discuss MedDRA's crucial role in global medical research through standardizing clinical trials

Scheduled for June 20, 2025, from 4:00 PM to 5:00 PM IST, this virtual session aims to demystify MedDRA (Medical Dictionary for Regulatory Activities), a globally recognized terminology used to harmonize medical information in regulatory communication and clinical research.<br />

Clinical Trials | 18/06/2025 | By Darshana |  148

Orbis India sees need to handle preventive ophthalmic issues by incorporating eye screenings into primary healthcare

Orbis India sees the need to advance preventive ophthalmic issues by incorporating eye screenings into primary healthcare. This is because primary care is the first point of contact in the healthcare system for most people, making it an ideal setting for preventive interventions.

Clinical Trials | 16/06/2025 | By Darshana |  245

Novavax's Covid-19-influenza combination and stand-alone influenza vaccine candidates showed robust immune responses and were well tolerated in initial coh

Novavax, Inc. announced results of the initial cohort of its Covid-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV) phase 3 trial that showed both the CIC and flu vaccine candidates induced immune responses similar to licensed comparators Nuvaxovid and Fluzone HD, respectively.

Clinical Trials | 13/06/2025 | By Darshana |  138

Biscado enters India's beta-blocker therapy space, addressing the growing burden of heart disease

Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India

Clinical Trials | 11/06/2025 | By Darshana |  192

Adcendo Receives FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

Tiffany-01 is an ongoing first-in-human Phase I multicenter, open-label, dose escalation study of ADCE-T02 as a monotherapy in patients with advanced solid tumors.

Clinical Trials | 27/02/2025 | By Aishwarya |  629